Early alterations in gene expression and cell morphology in a mouse model of Huntington's disease

Journal of Neurochemistry

Volumn 75, Issue 2, 2000, Pages 830-839

  Iannicola, C ^a   Moreno, S ^b   Oliverio, S ^a   Nardacci, R ^b,c   Ciofi Luzzatto, A ^b   Piacentini, M ^c,d  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b ROMA TRE UNIVERSITY   (Italy)

^c NATIONAL INSTITUTE FOR INFECTIOUS DISEASES L SPALLANZANI   (Italy)

^d UNIVERSITY OF TUSCIA   (Italy)

Author keywords

Apoptosis; Gene expression; Huntington's disease; Neurodegeneration; Neuronal inclusions

Indexed keywords

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CELL STRUCTURE; CONTROLLED STUDY; CORPUS STRIATUM; DOWN REGULATION; GENE CONTROL; GENE EXPRESSION; HIPPOCAMPUS; HUNTINGTON CHOREA; MOUSE; NERVE DEGENERATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL;

ANIMALS; APOPTOSIS; CORPUS STRIATUM; EXONS; GENE EXPRESSION REGULATION; HIPPOCAMPUS; HUMANS; HUNTINGTON DISEASE; IN SITU HYBRIDIZATION; IN SITU NICK-END LABELING; MICE; MICE, TRANSGENIC; NEURONS; TRINUCLEOTIDE REPEATS;

ANIMALIA;

EID: 0033914470     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.2000.0750830.x     Document Type: Article

References (33)

1. 2+-independent protein kinase C (nPKC) activation and its regulation by calcineurin activation. J. Biol. Chem. 273, 28392-28398.
2. Balcer-Kubiczek E. K., Zhang X. F., Han L. H., Harrison G. H., Davis C. C., Zhou X. J., Ioffe V., McCready W. A., Abraham J. M., and Meltzer S. J. (1998) BIGEL analysis of gene expression in HL60 cells exposed to X rays or 60 Hz magnetic fields. Radiat. Res. 150, 663-672.
3. Brandon E. P., Idzerda R. L., and McKnight G. S. (1997) PKA isoforms, neural pathways, and behaviour: making the connection. Curr. Opin. Neurobiol. 3, 397-403.
4. Datta R., Kojima H., Yoshida K., and Kufe D. (1997) Caspase-3-mediated cleavage of protein kinase C theta in induction of apoptosis. J. Biol. Chem. 272, 20317-20320.
5. Davies S. W., Turmaine M., Cozens B. A., DiFiglia M., Sharp A. H., Ross C. A., Scherzinger E., Wanker E. E., Mangiarini L., and Bates G. P. (1997) Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation. Cell 90, 537-548.
6. Díaz-Jullien C., Pérez-Estévez A., Covelo G., and Freire M. (1996) Prothymosin alpha binds histones in vitro and shows activity in nucleosome assembly assay. Biochim. Biophys. Acta 1296, 219-227.
7. Gandrillon O., Ferrand N., Michaille J. J., Roze L., Zile M. H., and Samarut J. (1994) c-erbA alpha/T3R and RARs control commitment of hematopoietic self-renewing progenitor cells to apoptosis or differentiation and are antagonized by the v-erbA oncogene. Oncogene 9, 749-758.
8. Gomez-Marquez J. and Rodriguez P. (1998) Prothymosin alpha is a chromatin-remodelling protein in mammalian cells. Biochem. J. 333, 1-3.
9. Grummt I., Rosenbauer H., Niedermeyer I., Maier U., and Ohrlein A. (1986) A repeated 18 bp sequence motif in the mouse rDNA spacer mediates binding of a nuclear factor and transcription termination. Cell 45, 837-846.
10. Gurney M. E. (1987) Neuroleukin: basic biology and functional interaction with human immunodeficiency virus. Immunol. Rev. 100, 203-223.
11. Gurney M. E., Heinrich S. P., Lee M. R., and Yin H. S. (1986) Molecular cloning and expression of neuroleukin, a neurotrophic factor for spinal and sensory neurons. Science 234, 566-574.
12. Harada H., Becknell B., Wilm M., Mann M., Huang L. J., Taylor S. S., Scott J. D., and Korsmeyer S. J. (1999) Phosphorylation and inactivation of BAD by mitochondria-anchored protein kinase A. Mol. Cell 3, 413-422.
13. Hodgson J. G., Agopyan N., Gutekunst C. A., Leavitt B. R., LePiane F., Singaraja R., Smith D. J., Bissada N., McCutcheon K., Nasir J., Jamot L., Li X. J., Stevens M. E., Rosemond E., Roder J. C., Phillips A. G., Rubin E. M., Hersch S. M., and Hayden M. R. (1999) A YAC mouse model for Huntington's disease with full-length mutant huntingtin, cytoplasmic toxicity, and selective striatal neurodegeneration. Neuron 23, 181-192.
14. Hotz M. A., Traganos F., and Darzynkiewicz Z. (1992) Changes in nuclear chromatin related to apoptosis or necrosis induced by the DNA topoisomerase II inhibitor fostriecin in MOLT-4 and HL-60 cells are revealed by altered DNA sensitivity to denaturation. Exp. Cell Res. 201, 184-191.
15. Karetsou Z., Sandaltzopoulos R., Frangou-Lazaridis M., Lai C. Y., Tsolas O., Becker P. B., and Papamarcaki T. (1998) Prothymosin alpha modulates the interaction of histone H1 with chromatin. Nucleic Acids Res. 26, 3111-3118.
16. Khélifa T. and Beck W. T. (1999) Merbarone, a catalytic inhibitor of DNA topoisomerase II, induces apoptosis in CEM cells through activation of ICE/CED-3-like protease. Mol. Pharmacol. 55, 548-556.
17. Klement I. A., Skinner P. J., Kaytor M. D., Yi H., Hersch S. M., Clark H. B., Zoghbi H. Y., and Orr H. T. (1998) Ataxin-1 nuclear localization and aggregation: role in polyglutamine-induced disease in SCA1 transgenic mice. Cell 95, 41-53.
18. Längst G., Blank T. A., Becker P. B., and Grummt I. (1997) RNA polymerase I transcription on nucleosomal templates: the transcription termination factor TTF-I induces chromatin remodeling and relieves transcriptional repression. EMBO J. 16, 760-768.
19. Liu Y. F. (1998) Expression of polyglutamine-expanded huntingtin activates the SEK1-JNK pathway and induces apoptosis in a hippocampal neuronal cell line. J. Biol. Chem. 273, 28873-28877.
20. Llanos S., Caelles C., Azorín I., Renau-Piqueras J., Fernández-Luna J. L., Boscá L., and Muñoz A. (1998) The c-erbAα protooncogene induces apoptosis in glial cells via a protein kinase C-and bcl-2-suppressible mechanism. J. Neurochem. 70, 2315-2326.
21. Mangiarini L., Sathasivam K., Seller M., Cozens B., Harper A., Hetherington C., Lawton M., Trottier Y., Lehrach H., Davies S. W., and Bates G. P. (1996) Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice. Cell 87, 493-506.
22. Meller N., Liu Y. C., Collins T. L., Bonnefoy-Bérard N., Baier G., Isakov N., and Altman A. (1996) Direct interaction between protein kinase C theta (PKC theta) and 14-3-3 tau in T cells: 14-3-3 overexpression results in inhibition of PKC theta translocation and function. Mol. Cell. Biol. 10, 5782-5791.
23. Mellon P. L., Clegg C. H., Correll L. A., and McKnight G. S. (1989) Regulation of transcription by cyclic AMP-dependent protein kinase. Proc. Natl. Acad. Sci. USA 86, 4887-4891.
24. Mizrachi Y. (1989) Neurotrophic activity of monomeric glucophosphoisomerase was blocked by human immunodeficiency virus (HIV-1) and peptides from HIV-1 envelope glycoprotein. J. Neurosci. Res. 23, 217-224.
25. Moulder K. L., Onodera O., Burke J. R., Strittmatter W. J., and Johnson E. M. Jr. (1999) Generation of neuronal intranuclear inclusions by polyglutamine-GFP: analysis of inclusion clearance and toxicity as a function of polyglutamine length. J. Neurosci. 19, 705-715.
26. Reddy P. H., Williams M., Charles V., Garrett L., Pike-Buchanan L., Whetsell W. O. Jr., Miller G., and Tagle D. A. (1998) Behavioural abnormalities and selective neuronal loss in HD transgenic mice expressing mutated full-length HD cDNA. Nat. Genet. 20, 198-202.
27. Rodríguez P., Viñuela J. E., Alvarez-Fernández L., and Gómez-Márquez J. (1999) Prothymosin alpha antisense oligonucleotides induce apoptosis in HL-60 cells. Cell Death Differ. 1, 3-5.
28. Schauber C., Chen L., Tongaonkar P., Vega I., Lambertson D., Potts W., and Madura K. (1998) Rad23 links DNA repair to the ubiquitin/proteasome pathway. Nature 391, 715-718.
29. Schilling G., Becher M. W., Sharp A. H., Jinnah H. A., Duan K., Kotzuk J. A., Slunt H. H., Ratovitski T., Cooper J. K., Jenkins N. A., Copeland N. G., Price D. L., Ross C. A., and Borchelt D. R. (1999) Intranuclear inclusions and neuritic aggregates in transgenic mice expressing a mutant N-terminal fragment of huntingtin. Hum. Mol. Genet. 8, 397-407.
30. Shelbourne P. F., Killeen N., Hevner R. F., Johnston H. M., Tecott L., Lewandoski M., Ennis M., Ramirez L., Li Z., Iannicola C., Littman D. R., and Myers R. M. (1999) A Huntington's disease CAG expansion at the murine hdh locus is unstable and associated with behavioural abnormalities in mice. Hum. Mol. Genet. 8, 763-774.
31. Sugimoto K., Yamada K., Egashira M., Yazaki Y., Hirai H., Kikuchi A., and Oshimi K. (1998) Temporal and spatial distribution of DNA topoisomerase II alters during proliferation, differentiation, and apoptosis in HL-60 cells. Blood 91, 1407-1417.
32. 2+-induced apoptosis through calcineurin dephosphorylation of BAD. Science 284, 339-343.
33. Wiley J. C., Wailes L. A., Idzerda R. L., and McKnight G. S. (1999) Role of regulatory subunits and protein kinase inhibitor (PKI) in determining nuclear localization and activity of the catalytic subunit of protein kinase A. J. Biol. Chem. 274, 6381-6387.